Better use of technology, the transition from analogue to digital, and greater innovation are at the heart of the 10 Year Health Plan. This includes plans to make the NHS app a gateway to the entire NHS, integrate AI into clinical pathways, create a new Health Data Research Service, make genomic sequencing at birth universal, utilise wearable technology in treatments as standard, and to improve uptake and adoption of medicines.

What are the potential benefits of greater use of technology and innovation in the NHS? Are there any risks associated with this? How deliverable is the 10 Year Health Plan’s vision for the use of technology and innovation in the NHS? What are the barriers to greater adoption of technology and innovation more broadly? And how can these be overcome? How can investment in technology and innovation be protected and prioritised?

To discuss these questions and more, we were joined by an expert panel including:

Matthew Chisambi, Director of Imperial College Health Partners

Johan Kahlström, President and Managing Director, UK and Ireland at Novartis Pharmaceuticals UK

Sam Roberts, Chief Executive of the National Institute for Health and Care Excellence

This event was chaired by Nick Davies, Programme Director at the Institute for Government.

We would like to thank Novartis Pharmaceuticals UK for kindly supporting this event.